Making the CASE: Chemopreventive use of Aspirin for Ovarian Cancer- Integrating Epidemiological Data to Evaluate Population Subgroups and Tumor Expression

Abstract

We hypothesize that the use of updated exposure information in cohort analyses will clarify and refine the ovarian cancer risk reductionassociated with aspirin, that there are subgroups of women who will derive the most benefit from daily aspirin use with respect to ovarian cancerchemoprevention, and that aspirin will preferentially reduce risk for ovarian cancers dependent on the tumor immune microenvironment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2021
Accession Number
AD1166361

Entities

People

  • Britton Trabert

Organizations

  • Geneva Foundation

Tags

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cancer
  • Consortiums
  • Data Analysis
  • Demographic Cohorts
  • Department Of Defense
  • Drug Therapy
  • Health
  • Heterogeneity
  • Infrastructure
  • Instructions
  • Ligation
  • Maryland
  • Medical Personnel
  • Neoplasms
  • Organizational Structure
  • Ovarian Cancer
  • Professional Development
  • Project Management
  • Public Health
  • Risk
  • Risk Factors
  • Women'S Health

Readers

  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.

Technology Areas

  • Biotechnology